FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

925726011000036106: Optiray-320 Ultraject (ioversol 678 mg / 1 mL) injection, 75 mL syringe (trade product unit of use)


Status: current, Defined. Date: 31-Jan 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3073721000168112 Optiray-320 Ultraject (ioversol 678 mg / 1 mL) injection, 75 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3073731000168110 Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe has manufactured dose form injection true Inferred relationship Some
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Is a trade product unit of use true Inferred relationship Some
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Is a Optiray-320 Ultraject true Inferred relationship Some
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Is a ioversol 678 mg (iodine 320 mg)/mL injection, 75 mL syringe true Inferred relationship Some
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe has manufactured dose form injection solution false Inferred relationship Some
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe has unit of use syringe true Inferred relationship Some 374943251
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe has Australian BoSS ioversol true Inferred relationship Some 374943250
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe has intended active ingredient ioversol true Inferred relationship Some 374943250

Inbound Relationships Type Active Source Characteristic Refinability Group
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 10 x 75 mL syringes has TPUU True Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Inferred relationship Some 1
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 20 x 75 mL syringes has TPUU True Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Inferred relationship Some 1
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 20 x 75 mL syringes has TPUU True Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Inferred relationship Some 1
Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 10 x 75 mL syringes has TPUU True Optiray-320 Ultraject 678 mg (iodine 320 mg)/mL injection, 75 mL syringe Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start